Compounds > mifepristone
Page last updated: 2024-08-23

mifepristone and losartan potassium

mifepristone has been researched along with losartan potassium in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's4 (50.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bohl, D; Heard, JM; Prevost, P; Rolland, E; Serguera, C1
Grafte-Faure, S; Leveque, C; Norris, V; Soria, C; Vannier, JP; Vasse, M1
Abruzzese, RV; Coleman, M; French, M; Godin, D; Howell, G; Mehta, V; Nelson, W; Nordstrom, JL; O'Malley, BW; Perrard, JL1
Abruzzese, RV; MacLaughlin, FC; Nordstrom, JL; Smith, LC1
Akiba, T; Inoshita, S; Kuwahara, M; Okado, T; Sasaki, S; Shimamura, H; Tanaka, H; Terada, Y1
Nordstrom, JL1
Jeton, F; Joseph, V; Marchant, D; Pichon, A; Richalet, JP; Soliz, J; Voituron, N1

Reviews

1 review(s) available for mifepristone and losartan potassium

ArticleYear
The antiprogestin-dependent GeneSwitch system for regulated gene therapy.
    Steroids, 2003, Volume: 68, Issue:10-13

    Topics: Anemia; Animals; Electroporation; Erythropoietin; Gene Transfer Techniques; Genetic Therapy; Humans; Mice; Mifepristone; Models, Genetic; Plasmids; Rats; Time Factors; Transgenes

2003

Other Studies

7 other study(ies) available for mifepristone and losartan potassium

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Control of erythropoietin secretion by doxycycline or mifepristone in mice bearing polymer-encapsulated engineered cells.
    Human gene therapy, 1999, Feb-10, Volume: 10, Issue:3

    Topics: 3T3 Cells; Animals; Blotting, Southern; Capsules; Dose-Response Relationship, Drug; Doxycycline; Erythropoietin; Gene Expression Regulation; Gene Transfer Techniques; Genetic Therapy; Hematocrit; Mice; Mifepristone; Retroviridae; Time Factors

1999
Effects of glucocorticoids and mineralocorticoids on proliferation and maturation of human peripheral blood stem cells.
    American journal of hematology, 1999, Volume: 62, Issue:2

    Topics: Adult; Aldosterone; Cells, Cultured; Colony-Forming Units Assay; Desoxycorticosterone; Erythropoietin; Glucocorticoids; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Interleukin-3; Mifepristone; Mineralocorticoids; Recombinant Proteins; Spironolactone; Triamcinolone Acetonide

1999
Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible GeneSwitch system.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2000, Volume: 2, Issue:3

    Topics: Animals; Base Sequence; Cell Line; DNA Primers; Endothelial Growth Factors; Erythropoietin; Female; Gene Expression Regulation; Humans; Ligands; Lymphokines; Mice; Mice, Inbred C57BL; Mifepristone; Muscle, Skeletal; Plasmids; Promoter Regions, Genetic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000
Regulated expression of plasmid-based gene therapies.
    Methods in molecular medicine, 2002, Volume: 69

    Topics: Animals; Electroporation; Erythropoietin; Female; Gene Expression Regulation; Genetic Therapy; HeLa Cells; Humans; Ligands; Male; Mice; Mice, Inbred C57BL; Mifepristone; Muscles; Plasmids; Transfection

2002
Ligand-regulatable erythropoietin production by plasmid injection and in vivo electroporation.
    Kidney international, 2002, Volume: 62, Issue:6

    Topics: Animals; Electroporation; Erythropoietin; Gene Expression; Genetic Therapy; Hematocrit; Hormone Antagonists; Humans; Injections, Intramuscular; Ligands; LLC-PK1 Cells; Male; Microinjections; Mifepristone; Plasmids; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Swine; Thigh

2002
Increased ventilation in female erythropoietin-deficient mouse line is not progesterone and estrous stage-dependent.
    Respiratory physiology & neurobiology, 2017, Volume: 245

    Topics: Animals; Erythropoietin; Estrous Cycle; Female; Hormone Antagonists; Hyperventilation; Hypoxia; Mice, Inbred CBA; Mice, Transgenic; Mifepristone; Plethysmography, Whole Body; Progesterone; Receptors, Progesterone; Respiration

2017